Dual antibody reactivity to β2-glycoprotein I and protein S: Increased association with thrombotic events in the antiphospholipid syndrome

Lupus

Volumn 11, Issue 4, 2002, Pages 215-220

  Erkan, D ^a   Zhang, H W ^b   Shriky, R C ^b,c   Merrill, J T ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Antiphospholipid syndrome; Dual reactivity

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTEIN S ANTIBODY; PROTHROMBIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; WESTERN BLOTTING;

ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BLOTTING, WESTERN; CROSS REACTIONS; GLYCOPROTEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDICTIVE VALUE OF TESTS; PROTEIN S; THROMBOSIS;

EID: 0036254689     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu178oa     Document Type: Article

References (24)

1. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop
2. Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency
3. Acquired protein S deficiency, likely due to anti-PS autoantibodies, following a thrombotic event in a patient with a systemic lupus erythematosus
4. Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus
5. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins
6. Familial protein S deficiency is associated with recurrent thrombosis
7. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus
8. The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S
9. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus
10. Risk factors for thrombosis in lupus patients
11. Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4Bp associated with recent history of venous thromboses, antiphospholipid antibodies and the antiphos-pholipid syndrome
12. Total and free protein S in systemic lupus erythematosus
13. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s
14. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies - A crucial role for acquired free protein S deficiency
15. Coumarin-induced skin necrosis associated with acquired protein S deficiency and antiphospholipid antibody syndrome
16. Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus
17. Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: Report of two cases
18. Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system
19. Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: Beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein
20. 'Anticardiolipin' autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding
21. Plasma concentrations of total/free and functional protein S are not decreased in systemic lupus erythematosus patients with lupus anticoagulant and/or antiphospholipid antibodies
22. Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant
23. Lupus anticoagulant-antiphospholipid antibodies and thrombophilia. Relation to protein C-protein S-thrombomodulin
24. 2-glycoprotein I inhibit the interaction between protein S and C4b-binding protein?